The course of COVID-19 in patients with severe asthma receiving biological treatment

References

• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, Untersmayr E, Hoffmann-Sommergruber K, Vultaggio A, Agache I, et al. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol Select. 2020;4:53–68. doi:10.5414/ALX02166E.
   PubMedGoogle Scholar
• Hartmann-Boyce J, Gunnell J, Drake J, Otunla A, Suklan J, Schofield E, Kinton J, Inada-Kim M, Richard Hobbs FD, Dennison P. Asthma and COVID-19: review of evidence on risks and management considerations. BMJ Evid Based Med. 2020. doi:10.1136/bmjebm-2020-111506.
   PubMedGoogle Scholar
• Hanon S, Brusselle G, Deschampheleire M, Louis R, Michils A, Peché R, Pilette C, Rummens P, Schuermans D, Simonis H, et al. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J. 2020;56(6):2002857. doi:10.1183/13993003.02857-2020.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Park J-Y, Lee HS, Suh J, Song JY, Byun MK, Cho JH, Kim HJ, Lee J-H, Park J-W, et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2021;57(3):2002226. doi:10.1183/13993003.02226-2020.
   PubMed Web of Science ®Google Scholar
• Rosenthal JA, Awan SF, Fintzi J, Keswani A, Ein D. Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(1):93–95. doi:10.1016/j.anai.2020.10.002.
   PubMed Web of Science ®Google Scholar
• Vultaggio A, Agache I, Akdis CA, Akdis M, Bavbek S, Bossios A, Bousquet J, Boyman O, Chaker AM, Chan S, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020;75(11):2764–2774. doi:10.1111/all.14407.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2020. [accessed 2020 May 14]. https://ginaasthma.org/wpcontent/uploads/2020/04/GINA-2020-fullreport-final-wms.pdf.
   Google Scholar
• Çakmak ME, Kaya SB, Bostan ÖC, Tuncay Glseren, Damadoğlu E, Karakaya Gl, Kalyoncu AF. Mortality due to COVID-19 in a patient with severe asthma receiving omalizumab treatment: A case report. Asthma Allergy Immunol. 2020;18(Supplement:1):27–29. doi:10.21911/aai.584.
   Google Scholar
• Ozturk AB, Baççıoğlu A, Soyer O, Civelek E, Şekerel BE, Bavbek S. Change in allergy practice during the COVID-19 pandemic. Int Arch Allergy Immunol. 2021;182(1):49–52. doi:10.1159/000512079.
   PubMed Web of Science ®Google Scholar
• Atayık E, Aytekin G. SARS-CoV-2 in a patient with persistent asthma taking omalizumab: the first case in Turkey. Asthma Allergy Immunol. 2020;18(Supplement:1):23–26.
   Google Scholar
• Rial MJ, Valverde M, Del Pozo V, González-Barcala FJ, Martínez-Rivera C, Muñoz X, Olaguibel JM, Plaza V, Curto E, Quirce S, et al. Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak. J Allergy Clin Immunol Pract. 2021;9(1):487–489.e1. doi:10.1016/j.jaip.2020.09.050.
   PubMed Web of Science ®Google Scholar
• Domínguez-Ortega J, López-Carrasco V, Barranco P, Ifim M, Luna JA, Romero D, Quirce S. Early experiences of SARS-CoV-2 infection in severe asthmatics receiving biologic therapy. J Allergy Clin Immunol Pract. 2020;8(8):2784–2786. doi:10.1016/j.jaip.2020.06.027.
   PubMed Web of Science ®Google Scholar
• Liu S, Cao Y, Du T, Zhi Y. Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2021;9(2):693–701. doi:10.1016/j.jaip.2020.11.054.
   PubMed Web of Science ®Google Scholar
• Kow CS, Capstick T, Hasan SS. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? Allergy. 2021;76(3):959–960. doi:10.1111/all.14589.
   PubMed Web of Science ®Google Scholar
• Jin M, Chen C, Huang J, Zhang F, Dong T, Zhang M, Yue H, Liu K, Li G, Hu K, et al. Clinical characteristics of COVID-19 patients with asthma in Wuhan, China: a retrospective cohort study. J Asthma. 2020:1–9. doi:10.1080/02770903.2020.1850768.
   Web of Science ®Google Scholar
• Chhiba KD, Patel GB, Vu THT, Chen MM, Guo A, Kudlaty E, Mai Q, Yeh C, Muhammad LN, Harris KE, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(2):307–314.e4. doi:10.1016/j.jaci.2020.06.010.
   PubMed Web of Science ®Google Scholar
• COVID-19 Situation Report Turkey. [accessed 2020 Oct 26]. https://covid19.saglik.gov.tr/Eklenti/39230/0/covid-19-weekly-situation-report.
   Google Scholar
• Teach SJ, Gill MA, Togias A, Sorkness CA, Arbes SJ, Calatroni A, Wildfire JJ, Gergen PJ, Cohen RT, Pongracic JA, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136(6):1476–1485. doi:10.1016/j.jaci.2015.09.008.
   PubMed Web of Science ®Google Scholar
• Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, Gruchalla RS, Kattan M, Teach SJ, Pongracic JA, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005–1015. doi:10.1056/NEJMoa1009705.
   PubMed Web of Science ®Google Scholar
• Benfante A, Scichilone N. Prioritizing care for severe asthma during SARS-CoV-2 pandemic. Pulmonology. 2020;27(3):189–190.
   PubMed Web of Science ®Google Scholar